Investment Team
Managing Director
Henrik joined Astorg in 2020 and is a member of the Technology team.
Prior to this, Henrik was a Vice President at Bain Capital Private Equity, where he joined in 2013 and worked on a number of investments across Europe. Henrik started his career at The Boston Consulting Group.
Since joining Astorg, Henrik has been involved in a number of transactions including Corsearch, Cytel and Nexpring Health.
Henrik holds a BSc from the Norwegian School of Economics (NHH), an MSc from the University of Oxford, and an MBA from Harvard Business School.
He is a Norwegian national and is based in London.
Nexpring Health
Nexpring Health is a global leader in Assisted Reproductive Technology(ART), providing consumables and equipment for in-vitro fertilization(IVF) procedures to hospitals, clinics and IVF labs across 115+ countries.
Investment year: 2024
Healthcare In Portfolio
Cytel
Cytel is widely recognized as the industry pioneer of adaptive clinical trials technology and a thought-leader in biostatistical science.
Investment year: 2021
Healthcare In Portfolio
Corsearch
Corsearch is a leading player in the brand risk and performance market, serving over 5,000 clients across multiple industries.
Investment year: 2021
Tech In Portfolio